Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 250.94 million compared to INR 125.39 million a year ago. Revenue was INR 282.85 million compared to INR 146.63 million a year ago. Net income was INR 80.56 million compared to net loss of INR 23.95 million a year ago. Basic earnings per share from continuing operations was INR 1.32 compared to basic loss per share from continuing operations of INR 0.39 a year ago. Diluted earnings per share from continuing operations was INR 1.32 compared to diluted loss per share from continuing operations of INR 0.39 a year ago.